Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy. Cardiopulmonary bypass equipment temporarily takes over the function of heart and lungs during an open-heart surgery. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cardiopulmonary bypass equipment devices market, including market shares of different players within the US. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the cardiopulmonary bypass equipment market in the US was LivaNova followed by Medtronic, Terumo, Getinge, Braile Biomedica and Technowood.
These devices are also known as heart-lung machine. The equipment is used to divert the blood returning to the heart, before it returns to the arterial circulation. It works both as a heart i.e. , pumps blood and as lungs i.e. , supply oxygenated blood to the RBCs.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the cardiopulmonary bypass equipment devices market within the US was expected to be over $100m in 2022.
For the latest complete market share analysis of cardiopulmonary bypass equipment device market in the US, buy the report here.